According to a new report Global Carrier Screening Market, published by KBV research, The Global Carrier Screening Market size is expected to reach $2,501.94 million by 2027, rising at a market growth of 10.81% CAGR during the forecast period.
The Expanded Carrier Screening market dominated the Europe Carrier Screening Market by Type in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $449.4 million by 2027, growing at a CAGR of 10.7 % during the forecast period.
The North America market dominated the Global Carrier Screening Market by Region in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $1,095.1 million by 2027. The Europe market is expected to witness a CAGR of 11% during (2021 - 2027). Additionally, The Asia Pacific market is expected to witness a CAGR of 12.9% during (2021 - 2027).
Full Report: https://www.kbvresearch.com/carrier-screening-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Quest Diagnostics, Incorporated, Thermo Fisher Scientific, Illumina, Inc., Eurofins Scientific Group, Invitae Corporation, OPKO Health, Inc., Fulgent Genetics, Sema4 OpCo, Inc., Myriad Genetics, Inc., and Natera, Inc.
By Type
By Technology
By End User
By Geography
Companies Profiled
Unique Offerings 
